Weightloss – Investorempires.com

Roche falls while Novo, Lilly gain on weight-loss drug report (OTCQX:RHHBY)

US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug By Reuters

Weight-loss drug demand will outstrip GLP-1 supply through 2024

Eli Lilly stock could soar 140% by 2028 as more people use weight-loss drugs, Goldman says

Pfizer drops weight-loss pill to rival Ozempic, Mounjaro

Weight-loss drug Wegovy debuts in UK even as Novo Nordisk struggles with supplies By Reuters

Biotech firms target weight-loss drugs without Wegovy’s side-effects By Reuters

Weight-loss drug pioneers aim to jump on Wegovy bandwagon By Reuters